<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药筛 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-24T20:26:52+08:00</updated>
  <subtitle>药品筛选</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>除恩替卡韦口服液，还有哪些“差异化”剂型品种？</title>
    <updated>2020-11-24T19:33:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/3r1ZxslHhhhVgSJgjPlTMA</id>
    <link href="https://mp.weixin.qq.com/s/3r1ZxslHhhhVgSJgjPlTMA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>扬子江 恩替卡韦口服液首家上市，普瑞巴林胶囊第3家过评 | 上周仿制药动态（11.16-11.22）</title>
    <updated>2020-11-23T18:27:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/pw_5OyZOYlt9PLy4Wu_-OA</id>
    <link href="https://mp.weixin.qq.com/s/pw_5OyZOYlt9PLy4Wu_-OA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>战胜新冠曙光更明：辉瑞公布新冠疫苗3期临床数据：有效率95%</title>
    <updated>2020-11-19T19:29:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/wWVscFNYTScNTa0cffkcEw</id>
    <link href="https://mp.weixin.qq.com/s/wWVscFNYTScNTa0cffkcEw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>学习心得：GLP-1降糖药中外市场差距大，国内潜力大</title>
    <updated>2020-11-18T23:58:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/S9aJaXxk3s7mlhV-aIUj4g</id>
    <link href="https://mp.weixin.qq.com/s/S9aJaXxk3s7mlhV-aIUj4g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>阿卡波糖、丙酚替诺福韦等重磅品种再添过评厂家 | 上周仿制药动态（11.9-11.15）</title>
    <updated>2020-11-16T16:58:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/icoyW5YzRbhmf3R-utVn_w</id>
    <link href="https://mp.weixin.qq.com/s/icoyW5YzRbhmf3R-utVn_w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>天晴速度：今年第6个首仿，泊马度胺获批；荣昌速度：ADC再加速</title>
    <updated>2020-11-13T16:37:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/5PGe9NvwKWIG7Wga8niijw</id>
    <link href="https://mp.weixin.qq.com/s/5PGe9NvwKWIG7Wga8niijw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>大热ADC，创新药的“练兵场”</title>
    <updated>2020-11-12T23:23:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/bgzNSCUgwSTlk-1Z3FuEhQ</id>
    <link href="https://mp.weixin.qq.com/s/bgzNSCUgwSTlk-1Z3FuEhQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>集采威力太大，代理商需多留意这些品种</title>
    <updated>2020-11-10T16:58:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/cGhchSMQZRpUNdAztBC7wg</id>
    <link href="https://mp.weixin.qq.com/s/cGhchSMQZRpUNdAztBC7wg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>泮托拉唑、艾司奥美拉唑等多个重磅注射剂过评价，普瑞巴林胶囊再添新成员 | 上周仿制药动态（11.2-11.8）</title>
    <updated>2020-11-09T16:38:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/dEYL0bicPGkEVyoUQd45PA</id>
    <link href="https://mp.weixin.qq.com/s/dEYL0bicPGkEVyoUQd45PA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>百亿PPI市场，集采后会怎样？</title>
    <updated>2020-11-05T19:36:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/uFEmgFdIARWrThLt_V9l0g</id>
    <link href="https://mp.weixin.qq.com/s/uFEmgFdIARWrThLt_V9l0g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>